. Author manuscript; available in PMC: 2017 Apr 1.

Published in final edited form as: Nanomedicine. 2015 Dec 3;12(3):589–600. doi: 10.1016/j.nano.2015.11.010

Table 2.

The IC₅₀ cytotoxicity assessment of gemcitabine base and gemcitabine in gelatin nanoparticles administered in Panc-1 human pancreatic adenocarcinoma cells.

Formulation	IC₅₀ Value (µM)
Gemcitabine	123.9 ± 23.9^*
SPDP	N/A
Gem-SPDP	8.39 ± 1.79
Gem-Gel Nanoparticles	24.76 ± 7.99
Gem-Gel-PEG	20.08 ± 6.97
Gem-Gel-PEG-EGFR	17.08 ± 2.32

Mean ± S.D. (n = 3)